Cart
sales@molnova.com
FT-827
CAS No. 1959537-86-0
FT-827( FT827 | FT 827 )
Catalog No. M13071 CAS No. 1959537-86-0
A novel potent, specific, covalent USP7 inhibitor with Kd of 7.8 uM (USP7 catalytic domain).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 553 | In Stock |
|
| 10MG | 683 | In Stock |
|
| 25MG | 901 | In Stock |
|
| 50MG | 1097 | In Stock |
|
| 100MG | 1469 | In Stock |
|
| 200MG | 2009 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFT-827
-
NoteResearch use only, not for human use.
-
Brief DescriptionA novel potent, specific, covalent USP7 inhibitor with Kd of 7.8 uM (USP7 catalytic domain).
-
DescriptionA novel potent, specific, covalent USP7 inhibitor with Kd of 7.8 uM (USP7 catalytic domain); modifies the catalytic Cys223 of USP7 and inhibits the enzyme with kinact/Ki of 66 M-1s-1, display good USP7 selectivity in a panel of 38 deubiquitinases (DUBs).
-
In Vitro——
-
In Vivo——
-
SynonymsFT827 | FT 827
-
PathwayProteasome/Ubiquitin
-
TargetDUB
-
RecptorDUB
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1959537-86-0
-
Formula Weight548.618
-
Molecular FormulaC27H28N6O5S
-
Purity>98% (HPLC)
-
SolubilityDMSO : 125 mg/mL 227.85 mM
-
SMILESO=C(N1CCC(O)(CN2C=NC(N(C)N=C3)=C3C2=O)CC1)C(C=C4)=CC=C4C5=CC=CC=C5NS(C=C)(=O)=O
-
Chemical NameN-(4'-(4-hydroxy-4-((1-methyl-4-oxo-1,4-dihydro-5H-pyrazolo[3,4-d]pyrimidin-5-yl)methyl)piperidine-1-carbonyl)-[1,1'-biphenyl]-2-yl)ethenesulfonamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Turnbull AP, et al. Nature. 2017 Oct 26;550(7677):481-486.
molnova catalog
related products
-
ML364
A potent, selective, reversible deubiquitinase USP2 inhibitor with IC50 of 1.1 uM in biochemical assay.
-
P-50429
P-50429 (P50429, P 50429) is a potent, selective, covalent deubiquitinase USP7 (EC50=0.42 uM)/USP47 (EC50=1.0 uM) inhibitor.
-
I-138
I-138 is an orally active and potent reversible inhibitor of USP1-UAF1.I-138 induces mono-ubiquitination of FANCD2 and PCNA and inhibits USP1 auto-cleavage in cells.
